Tivozanib

Tivozanib is a targeted cancer medication used primarily to treat advanced kidney cancer. It works by blocking specific proteins called angiogenesis pathways, which tumors use to develop new blood vessels. By inhibiting these pathways, Tivozanib reduces the tumor's blood supply, slowing its growth and spread. It is typically administered orally and is selected for patients who need a treatment option that specifically targets tumor growth mechanisms, offering a focused approach with potentially fewer side effects compared to traditional chemotherapy.